Japanese Society of Drug Delivery Systems, the Massachusetts Institute of Technology, and Kyoto University, Westin Maui Resort & Spa, Lahaina, Maui, HAWAII
12/16/09 - 12/20/09
Agenda Wednesday, December 16, 2009 2:30-5:30pm
Registration - Ocean Lanai Terrace 5:45–6:55pm
Welcome Reception Evening Plenary Session
7:00-7:05pm
Introduction: Robert Langer and Yasuhiko Tabata Discussion Leader: Mike Sefton 7:05-7:45pm
John Santini
President and Chief Executive Officer, MicroCHIPS, Inc.
Addressing drug delivery challenges with intelligent implantable devices 7:45-8:25pm
Yasuyoshi Watanabe
Director, RIKEN Center for Molecular Imaging Science
Drug delivery systems and PK/PD studies with molecular imaging 8:25-8:55pm - Refreshment Break 8:55-9:35pm
Francis Szoka
Professor of Biopharmaceutical Sciences, University of California, San Francisco
Back to the future: New lipids to solve an old problem: Drug and nucleic acid delivery 9:35-10:15pm
Joseph DeSimone
Chancellor’s Eminent Professor of Chemistry; Kenan Jr. Distinguished Professor of Chemical Engineering, University of North Carolina-Chapel Hill and North Carolina State University
On the role of size, shape, chemistry and deformability on drug delivery systems
Thursday, December 17, 2009 7:00 - 8:00am
Registration, Ocean Lanai Terrace Morning Plenary Session
Discussion Leader: Allan Hoffman 8:30-9:10am
Kazunori Kataoka
Professor, University of Tokyo
Block copolymer micelles and vesicles as nanocarriers for gene and drug delivery 9:10-9:50am
Henry Brem
Director of Neurosurgery and Professor, Johns Hopkins School of Medicine
New approaches to treating brain tumors 9:50-10:30am
Shigeru Kawakami
Assistant Professor, Kyoto University
Development and evaluation of organ-press mediated in vivo gene transfection methods of plamid DNA and siRNA 10:30-11:00am – Refreshment Break 11:00-11:40am
Rodney Pearlman
President and Chief Executive Officer, Nuon Therapeutics, Inc.
Twenty years of protein drug delivery: The good, the bad, the ugly 11:40am-12:20pm
Christine Bunt
Chief Operating Officer and Founder, TARIS Biomedical
Drug-device convergence for diseases of the bladder Afternoon Unscheduled Evening Plenary Session 7:00-7:40pm
Victor Kotelianski
Vice President of Research, Alnylam Pharmaceuticals
Achieving therapeutic silencing by RNAi 7:40-8:20pm
Juichi Ito
Professor and Chairman of the Department of Otolaryngology-Head and Neck Surgery, Kyoto University
New drug delivery systems for inner ear diseases 8:20-8:50pm - Refreshment Break 8:50-9:30pm
Sung Wan Kim
Distinguished Professor of Pharmaceutics and Pharmaceutical Chemistry, University of Utah
Newly designed polymers for the delivery of siRNA 9:30-10:10pm
Lloyd Johnston
Vice President, Pharmaceutical Research and Development, Selecta Biosciences, Inc.
Title TBA
Friday, December 18, 2009 Morning Plenary Session 8:30-9:10am
Yoshinobu Baba
Professor, Nagoya University
Nanotechnology for cancer stem cell diagnosis and in vivo stem cell imaging for tissue engineering 9:10-9:50am
Gerald Bernstein
Vice President, Medical Affairs, Director, Generex Biotechnology Corp
Buccal delivery of insulin, etc: The evolving paradigm of natural history and treatment for diabetes and prediabetes 9:50-10:30am
Yasufumi Kaneda
Professor, Osaka University
Novel anti-cancer strategies using HVJ (Sendai virus) envelope 10:30-11:00am – Refreshment Break 11:00-11:40am
Nicholas Peppas
Fletcher Stuckey Pratt Chair in Engineering, University of Texas – Austin
Recognition and delivery: The next generation of medical microdevices 11:40am-12:20pm
Kenji Hyodo
Scientist, Eisai Co., Ltd.
Inhibition of cancer metastasis by targeted delivery of antioxidant enzymes Afternoon Unscheduled Evening Session – Poster Session 1 7:30pm – 9:30pm
Oral Presentation of Posters - Selected from Poster Session #1
8:30pm – Refreshment Break Session ends at approximately 10:00 pm
Saturday, December 19, 2009 Morning Plenary Session
8:30-9:10am
Koji Hanai
Scientist, Dainippon Sumitomo Pharma Co., Ltd.
Progress of atelocollagen-mediated drug delivery systems for nucleic acid medicines 9:10-9:50am
Jeff Hrkach
Vice President, Pharmaceutical Sciences, BIND Biosciences, Inc
The development of BIND targeted nanotherapeutics 9:50-10:30am
Eric Tomlinson
President and Chief Executive Officer, Altea Therapeutics Corp.
The efficient transdermal delivery of biotherapeutics from a conventional skin patch 10:30-11:00am - Refreshment Break 11:00-11:40am
Hideyuki Okano
Professor and Chairman, Department of Physiology, Keio University
ES/iPS cells based cell therapy for damaged CNS 11:40am-12:20pm
Oliver Fetzer
President and Chief Executive Officer, Cerulean Pharma, Inc.
Title TBA Afternoon Unscheduled Evening Plenary Session 7:30-8:10pm
John Patton
Founder and Chief Scientific Officer, Dance Pharma
Inhaled medicines for systemic action 8:10-8:50pm
Takayuki Yoshida
Scientist, Astellas Pharma, Inc.
pH-sensitive PEG release from nanoparticles for gene delivery 8:50-9:20pm - Refreshment Break 9:20-10:00pm
Shaoyi Jiang1 and Christopher Loose2
SAB Co-Chairman1; Chief Technology Officer2, Semprus BioSciences
Functional surfaces for medical devices
Sunday, December 20, 2009 Morning Plenary Session
8:30-9:10am
Howie Rosen
Lecturer, Stanford University
Ouch! The role of drug delivery in pain management 9:10-9:50am
Yuichi Sugiyama
Professor, University of Tokyo
Evolutional drug development with the use of microdosing clinical trial: Quantitative prediction of ADME with PET imaging 9:50-10:20am – Refreshment Break 10:20-11:00am
Maria Palasis
Executive Vice President, Research and Development, Arsenal Medical
Combination products in drug delivery: Enabling site specific therapy with medical devices 11:00-11:40am
Ronald E. Peeples
AVP, Drug Product Development, Wyeth BioPharma
Title TBA Afternoon Unscheduled Evening Session – Poster Session 2 7:30pm
Oral Presentation Of Posters - Selected From Poster Session #2
8:30pm - Refreshment Break Session Ends at Approximately 10:00 p.m. Thank you for participating - we hope to see you again at the 11th Symposium in 2011.
|